The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort - Concepedia

Concepedia

Publication | Open Access

The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort

DOI Full Paper Access

145

Citations

15

References

2019

Year

Diane Damotte, Sarah Warren, Jennifer Arrondeau, Pascaline Boudou‐Rouquette, Audrey Mansuet‐Lupo, Jérôme Biton, Hanane Ouakrim, Marco Alifano, Claire Gervais, Audrey Bellesœur,

Journal of Translational Medicine

References

	Year	Citations

Page 1